The global burden of mental, neurological and substance use disorders: An analysis from the Global Burden of Disease Study 2010.
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders. METHOD: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs. RESULTS: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific. CONCLUSION: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“which is significant contributor to the global burden of disease [7, 43].”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Anxiety disorders cause 10.4% of the Disability Adjusted Life Years (DALYs) lost due to neurological, mental, substance use disorders and account for 1.1% of the global burden of disease worldwide, that is a total of 26,800,000 DALYs worldwide (Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015).”
From Treatment gap for anxiety disorders is global: Results of the World Mental Health Surveys in 21 countries (2018) · cites this paper as Whiteford, Ferrari, Degenhardt, Feigin, & Vos, 2015
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As described above, postpartum psychosis is a key marker for the risk of future affective disorder”
From The global prevalence of postpartum psychosis: a systematic review (2017) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“In 2010, mental, neurological and substance abuse disorders accounted for 10.4% of all disability-adjusted life-years globally.21”
From Climate change, climate-related disasters and mental disorder in low- and middle-income countries: a scoping review (2021) · cites this paper as [21]
In the citing paper
“Recent prevalence estimates indicate 10.7% of the world’s population live with a mental health disorder, and the number of years lived with a mental health disorder has increased by 13.5% from 2007 to 2017”
From Explaining adults’ mental health help-seeking through the lens of the theory of planned behavior: A scoping review (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · cited 7×
“Overall, GBD 2010 findings highlighted a shift in burden from communicable to noncommunicable diseases and from YLLs to YLDs [1,11].”
InfluentialSelf-citationVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationWorld Population Prospects The 2006 Revision
Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,970
(1996) · Cited by 6,884
Whiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Self-citationDiagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR )
Segal, D. L. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0271 · Cited by 4,666
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Self-citation
Cited by
Items 301–400 of 1,000
White, R. L., Bennie, J. A., Abbott, G., & Teychenne, M. J. (2020) · BMC Public Health · doi:10.1186/s12889-020-09112-7 · Cited by 39
Snowden, L. R., & Snowden, J. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073568 · Cited by 34
Watanabe‐Galloway, S., Madison, L. S., Watkins, K., Nguyen, A., & Chen, L. (2015) · Rural and Remote Health · doi:10.22605/rrh3392 · Cited by 34
Pineal volume and evening melatonin in young people with affective disorders
Carpenter, J. S., Abelmann, A. C., Hatton, S. N., Robillard, R., Hermens, D. F., Bennett, M. R., Lagopoulos, J., & Hickie, I. B. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9650-2 · Cited by 38
Ciobanu, L. G., Sachdev, P. S., Trollor, J. N., Reppermund, S., Thalamuthu, A., Mather, K. A., Cohen‐Woods, S., Stacey, D., Toben, C. G., Schubert, K. O., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.017 · Cited by 39
Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia
Santos, B., González–Fraile, E., Zabala, A., Guillén, V., Rueda, J. R., & Ballesteros, J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118805496 · Cited by 34
Beck, C., Pedersen, C. B., Plana‐Ripoll, O., Dalsgaard, S., Debost, J.-C., Laursen, T. M., Musliner, K. L., Mortensen, P. B., Pedersen, M. G., Petersen, L. V., et al. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13682 · Cited by 36
“6,22 We observed striking differences in the cumulative incidence of mental disorders between males and females.”
BackgroundMoscoso‐Castro, M., López‐Cano, M., Gracia‐Rubio, I., Ciruela, F., & Valverde, O. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.027 · Cited by 36
“Psychiatric, neurological and substance use disorders are the leading cause of the disease burden worldwide (Whiteford et al., 2015).”
BackgroundVancampfort, D., Stubbs, B., Mugisha, J., Firth, J., Schuch, F. B., & Koyanagi, A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.02.088 · Cited by 33
Effect of grip strength on mental health
Kim, J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.017 · Cited by 38
Ikonte, C. O., Prigmore, H. L., Dawson, A. Z., & Egede, L. E. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.010 · Cited by 36
Prevention in Autism Spectrum Disorder: A Lifelong Focused Approach
Francis, K., Karantanos, G., Al-Ozairi, A., & AlKhadhari, S. (2021) · Brain Sciences · doi:10.3390/brainsci11020151 · Cited by 38
Morabbi, M.-J., Razaghi, E., Moazen-Zadeh, E., Safi-Aghdam, H., Zarrindast, M. R., Vousoghi, N., & Akhondzadeh, S. (2018) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000200 · Cited by 32
Domhardt, M., Nowak, H., Engler, S., Baumel, A., Grund, S., Mayer, A., Terhorst, Y., & Baumeister, H. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102084 · Cited by 32
Murray, L. K., Haroz, E. E., Doty, B., Singh, N. S., Bogdanov, S., Bass, J., Dorsey, S., & Bolton, P. (2018) · Trials · doi:10.1186/s13063-018-2752-y · Cited by 30
Tönnies, J., Hartmann, M., Wensing, M., Szécsényi, J., Icks, A., Friederich, H., & Haun, M. W. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030003 · Cited by 35
Beesdo‐Baum, K., Voss, C., Venz, J., Hoyer, J., Berwanger, J., Kische, H., Ollmann, T. M., & Pieper, L. (2020) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1804 · Cited by 32
Paz, C., Mascialino, G., & Evans, C. (2020) · BMC Psychology · doi:10.1186/s40359-020-00443-z · Cited by 34
Potential neurological manifestations of COVID-19: a narrative review
Pergolizzi, J. V., Raffa, R. B., Varrassi, G., Magnusson, P., LeQuang, J. A., Paladini, A., Taylor, R., Wollmuth, C. E., Breve, F., Chopra, M., et al. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2020.1837503 · Cited by 37
Koly, K. N., Abdullah, R., Shammi, F. A., Akter, T., Hasan, M. T., Eaton, J., & Ryan, G. K. (2021) · Community Mental Health Journal · doi:10.1007/s10597-021-00790-0 · Cited by 33
Aliev, A. A., Roberts, T., Magzumova, S., Panteleeva, L., Yeshimbetova, S. Z., Krupchanka, D., Sartorius, N., Thornicroft, G., & Winkler, P. (2021) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-021-02064-2 · Cited by 34
“9, F40-F43) for their high prevalence in the population [17, 18].”
BackgroundEyford, B. A., Singh, C. S. B., Abraham, T., Munro, L., Choi, K. B., Hildebrandt, R., Hill, T., Welch, I. D., Okon, M., Vitalis, T. Z., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.611367 · Cited by 37
Harikrishnan, U., & Sailo, G. L. (2021) · PubMed Central · doi:10.4103/ijcm.ijcm_451_20 · Cited by 32
eHealth Interventions to Treat Substance Use in Pregnancy: A Systematic Review and Meta-Analysis
Silang, K., Sanguino, H., Sohal, P. R., Rioux, C., Kim, H. S. A., & Tomfohr‐Madsen, L. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18199952 · Cited by 37
George, E. S., Davidson, I. A. K., Masri, A. E., Meade, T., & Kolt, G. S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074399 · Cited by 32
Alvi, M. H., Ashraf, T., Naz, F., Sardar, A., Ullah, A., Patel, A. K., Kiran, T., Gumber, A., & Husain, N. (2023) · BJPsych Bulletin · doi:10.1192/bjb.2023.76 · Cited by 47
Seasonality of hospital admissions for mental disorders in Hanoi, Vietnam
Trang, P. M., Rocklöv, J., Giang, K. B., & Nilsson, M. (2016) · Global Health Action · doi:10.3402/gha.v9.32116 · Cited by 32
Establishing political priority for global mental health: a qualitative policy analysis
Iemmi, V. (2022) · Health Policy and Planning · doi:10.1093/heapol/czac046 · Cited by 31
“The epidemiological and economic burden of mental disorders has increased worldwide over the past three decades (Bloom et al., 2011; Whiteford et al., 2013; 2015), partly due to demographic and epidemiological transitions (e.g. increasing population in age groups more likely to experience mental…”
BackgroundAstrocyte-derived lactate in stress disorders
Chamaa, F., Magistretti, P. J., & Fiumelli, H. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106417 · Cited by 32
“The widespread impact of stress and mental illness manifests as a considerable strain, positioning these issues as primary contributors to disability on a global scale (Chisholm et al., 2016; Whiteford et al., 2015).”
Masoudkabir, F., Shafiee, A., Heidari, A., Mohammadi, N. S. H., Tavakoli, K., Jalali, A., Nayebirad, S., Alaeddini, F., Saadat, S., Vasheghani‐Farahani, A., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05561-1 · Cited by 32
“Nevertheless, with the introduction of various health policies, substance use has still significantly increased in recent years [15–18].”
BackgroundParity of esteem: Addressing the inequalities between mental and physical healthcare
Mitchell, A. J., Hardy, S., & Shiers, D. (2017) · BJPsych Advances · doi:10.1192/apt.bp.114.014266 · Cited by 35
Mental health problems among clients with substance use problems: a nationwide time-trend study
Kuussaari, K., Karjalainen, K., & Niemelä, S. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01753-3 · Cited by 32
Reece, A. S., & Hulse, G. K. (2019) · Global Pediatric Health · doi:10.1177/2333794x19894798 · Cited by 31
Soltmann, B., Neumann, A., March, S., Weinhold, I., Häckl, D., Kliemt, R., Baum, F., Romanos, M., Schwarz, J., von Peter, S., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.659773 · Cited by 31
The burden of schizophrenia in the Middle East and North Africa region, 1990–2019
Safiri, S., Noori, M., Nejadghaderi, S. A., Shamekh, A., Sullman, M. J. M., Collins, G. S., & Kolahi, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-59905-8 · Cited by 35
Resilient Coping Moderates the Effect of Trauma Exposure on Depression
Sinclair, V. G., Wallston, K. A., & Strachan, E. D. (2016) · Research in Nursing & Health · doi:10.1002/nur.21723 · Cited by 31
Chen, W., Xia, X., Song, N., Wāng, Y., Zhu, H., Deng, W., Kong, Q., Pan, X., & Qin, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164295 · Cited by 31
Correct recognition and continuum belief of mental disorders in a nursing student population
Seow, E., Chua, B. Y., Xie, H., Jia, W., Ong, H. L., Abdin, E., Chong, S. A., & Subramaniam, M. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1447-3 · Cited by 32
“5% of global years lived with disability (YLDs), making them the leading cause of YLDs [3].”
BackgroundInfluentialTowards a public health approach to psychotic disorders
Anderson, K. K. (2019) · The Lancet Public Health · doi:10.1016/s2468-2667(19)30054-4 · Cited by 31
Cartmel, B., Hughes, M., Ercolano, E. A., Gottlieb, L. T., Li, F., Zhou, Y., Harrigan, M., Ligibel, J. A., von Gruenigen, V. E., Gogoi, R. P., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.02.036 · Cited by 33
Zimba, C. C., Akiba, C. F., Matewere, M., Thom, A., Udedi, M. M., Masiye, J., Kulisewa, K., Go, V. F.-L., Hosseinipour, M. C., Gaynes, B. N., et al. (2021) · International Journal of Mental Health Systems · doi:10.1186/s13033-021-00480-0 · Cited by 34
Bryant, E., Koemel, N. A., Martenstyn, J. A., Marks, P., Hickie, I. B., & Maguire, S. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100786 · Cited by 41
Salvador‐Carulla, L., & Symonds, S. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000237 · Cited by 34
Clinical role of brexpiprazole in depression and schizophrenia
Parikh, N., Robinson, D., & Clayton, A. H. (2017) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s94060 · Cited by 31
Virtanen, M., Ervasti, J. M., Mittendorfer‐Rutz, E., Lallukka, T. M., Kjeldgård, L., Friberg, E., Kivimäki, M., Lundström, E., & Alexanderson, K. A. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-01216-2 · Cited by 33
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Sarwar, M. R., Atif, M., Scahill, S. L., Saqib, A., Qamar-uz-Zaman, M., & Babar, Z. (2017) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-017-0112-z · Cited by 30
“Thus neurological disorders afflicts both high income and low income countries with comparatively high treatment rates in high income countries [36].”
Perceived Marital Support and Incident Mental Illness: Evidence from the National Comorbidity Survey
Feder, K. A., Heatherington, L., Mojtabai, R., & Eaton, W. W. (2018) · Journal of Marital and Family Therapy · doi:10.1111/jmft.12343 · Cited by 31
Hudson, C. G. (2019) · Health & Place · doi:10.1016/j.healthplace.2019.01.006 · Cited by 30
“…been driven by the growing awareness, based on the work of the World Health Organization's Mental Health Program (Saxena et al., 2011) and the Global Burden of Disease study (Whiteford et al., 2015) that have documented that mental illness is now one of the most disabling of all health conditions.”
BackgroundDadson, D. A., Annor, F., & Yendork, J. S. (2018) · Issues in Mental Health Nursing · doi:10.1080/01612840.2018.1496208 · Cited by 35
Crouse, J. J., Chitty, K. M., Iorfino, F., Carpenter, J. S., White, D., Nichles, A., Zmicerevska, N., Tickell, A. M., Lee, R. S. C., Naismith, S. L., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.12 · Cited by 31
Villatte, A., Piché, G., & Benjamin, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.793344 · Cited by 30
Is maternal depression related to mother and adolescent reports of family functioning?☆
Pérez, J. C., Coo, S., & Irarrázaval, M. (2018) · Journal of Adolescence · doi:10.1016/j.adolescence.2017.12.013 · Cited by 31
Mwangala, P. N., Kariuki, S. M., Nyongesa, M. K., Mwangi, P. M., Chongwo, E. J., Newton, C. R. J. C., & Abubakar, A. A. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.05.032 · Cited by 28
“Epilepsy, a common neurological disorder, accounts for a significantly high proportion of the global burden of disease [1].”
Wojciechowski, T. W. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1741637 · Cited by 29
Kattan, D., Barsa, C., Mekhijian, S., Shakkour, Z., Jammoul, M., Doumit, M., Zabala, M. C. P., Darwiche, N., Eid, A. H., Mechref, Y. S., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104969 · Cited by 28
Hou, L., Liu, Y., Zhu, C., Miao, J., Zhou, W., Tang, Y., Meng, H., & Liu, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1107781 · Cited by 31
“More than 350 million people suffer from MDD worldwide (Smith, 2014), and it has become the second leading cause of disability, as measured by years lived with disability (Whiteford et al., 2015).”
BackgroundNie, P., Zhao, K., Ma, D., Liu, H., Amin, S., & Yasin, I. (2024) · Sustainability · doi:10.3390/su16198693 · Cited by 36
Hajebi, A., Ahmadzad-Asl, M., Davoudi, F., & Ghayyomi, R. (2016) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.17795/ijpbs-4398 · Cited by 35
Júnior, R. G. D. O., Ferraz, C. A. A., Silva, J. C., Teles, R. B. D. A., Silva, M. G., Diniz, T. C., dos Santos, U. S., de Souza, A. V., Nunes, C. E. P., Salvador, M. J., et al. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.04.009 · Cited by 28
International Epilepsy Day - A day notified for global public education & awareness
Mehndiratta, M., & Wadhai, S. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.155531 · Cited by 29
Ahrens, J., Kokota, D., Mafuta, C., Konyani, M., Chasweka, D., Mwale, O., Stewart, R. C., Osborn, M., Chikasema, B., Mcheka, M., et al. (2020) · International Journal of Mental Health Systems · doi:10.1186/s13033-020-00345-y · Cited by 27
Escala de Risco de Depressão na Gravidez: elaboração de um modelo teórico
Silva, M. M. D. J., & Clápis, M. J. (2021) · Revista da Escola de Enfermagem da USP · doi:10.1590/s1980-220x2020027503780 · Cited by 27
“A depressão caracteriza-se como um dos transtornos mentais mais frequentes e difundidos no mundo e um dos principais contribuintes para o ônus global da doença(1).”
BackgroundYu, S.-H., Wang, L.-T., SzuTu, W.-J., Huang, L.-C., Shen, C., & Chen, C.-Y. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112916 · Cited by 29
Morris, K., Nami, M., Bolanos, J. F., Lobo, M. A., Sadri-Naini, M., Fiallos, J., Sanchez, G. E., Bustos, T., Chintam, N., Amaya, M., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215190 · Cited by 30
Lee, B.-J., Lamichhane, D. K., Jung, D.-Y., Moon, S.-H., Kim, S., & Kim, H. (2015) · Industrial Health · doi:10.2486/indhealth.2015-0191 · Cited by 29
Zhao, D., Lustria, M. L. A., & Hendrickse, J. (2017) · Patient Education and Counseling · doi:10.1016/j.pec.2017.01.004 · Cited by 31
Niigaki, S. T., Peres, F. F., Ferreira, L. B. T., Libânio, T. C., Gouvêa, D. A., Levin, R. R., de Almeida, V., Silva, N. D., Diana, M. C., Suiama, M. A., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.020 · Cited by 28
“Schizophrenia accounts for 0.5% of the total disability-adjusted life years (DALYs) (Whiteford et al., 2015).”
InfluentialPu, Z., Peng, C. Y., Xie, X., Luo, M., Zhu, H., Feng, R. Y., & Xiong, L. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.03.026 · Cited by 28
Walker, R. J., Campbell, J. A., Dawson, A. Z., & Egede, L. E. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01719-5 · Cited by 51
Epidemiological status of depressive disorders in the Middle East and North Africa from 1990 to 2019
Moradinazar, M., Mirzaei, P., Moradivafa, S., Saeedi, M., Basiri, M., & Shakiba, M. (2022) · Health Promotion Perspectives · doi:10.34172/hpp.2022.39 · Cited by 26
Akerele, O. A., & Cheema, S. K. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104778 · Cited by 28
Iseselo, M. K., & Ambikile, J. S. (2020) · Psychiatry Journal · doi:10.1155/2020/3607414 · Cited by 28
“It is estimated that mental illness and other psychological disorders account for about 10% of the disability-adjusted life years (DALYs) [1].”
BackgroundLuitel, N. P., Jordans, M. J. D., Subba, P., & Komproe, I. H. (2020) · BMC Family Practice · doi:10.1186/s12875-020-01266-y · Cited by 28
“4% of the global burden of disease in terms of disability adjusted life years (DALYs) [1].”
BackgroundCoates, D., Coppleson, D., & Travaglia, J. (2021) · Journal of Interprofessional Care · doi:10.1080/13561820.2020.1862771 · Cited by 26
Kautzky, A., Heneis, K., Stengg, K., Fröhlich, S., & Kautzky‐Willer, A. (2021) · Neuroendocrinology · doi:10.1159/000514484 · Cited by 79
Tadi, N. F., Pillay, K., Ejoke, U. P., & Khumalo, I. P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.873292 · Cited by 27
Assari, S., & Zadeh, E. M. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00178 · Cited by 32
Clinically useful brain imaging for neuropsychiatry: How can we get there?
Milham, M. P., Craddock, R. C., & Klein, A. (2017) · Depression and Anxiety · doi:10.1002/da.22627 · Cited by 26
“Contests such as the ADHD-200 Global Competition or the Alzheimer’s Disease Big Data DREAM Challenge (https://www.synapse.org/Synapse:syn2290704) can help to accelerate the recruitment of investigators from other disciplines (Allen et al. 2016)(Milham 2012).”
BackgroundInfluentialChild Community Mental Health Services in Asia Pacific and Singapore’s REACH Model
Lim, C., Loh, H., Renjan, V., Tan, J., & Fung, D. S. S. (2017) · Brain Sciences · doi:10.3390/brainsci7100126 · Cited by 27
Åberg, K. A., Shabalin, A. A., Chan, R. F., Zhao, M., Kumar, G., van Grootheest, G., Clark, S. L., Xie, L. Y., Milaneschi, Y., Penninx, B. W. J. H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0205-8 · Cited by 29
Howarth, E., Vainre, M., Humphrey, A., Lombardo, C., Hanafiah, A. N., Anderson, J., & Jones, P. B. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022936 · Cited by 29
Dugdale, S., Elison, S., Semper, H., Ward, J., & Davies, G. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1652381 · Cited by 28
Systematic Review of Pain Severity and Opioid Craving in Chronic Pain and Opioid Use Disorder
MacLean, R. R., Spinola, S., Manhapra, A., & Sofuoglu, M. (2019) · Pain Medicine · doi:10.1093/pm/pnz228 · Cited by 45
ZareMobini, F., Kazemi, A., & Farajzadegan, Z. (2018) · Reproductive Health · doi:10.1186/s12978-018-0488-5 · Cited by 27
(2020) · Pacific Asia journal of the Association for Information Systems · doi:10.17705/1pais.12201 · Cited by 26
Yule, A. M., Wilens, T. E., Martelon, M., Rosenthal, L., & Biederman, J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.01.021 · Cited by 25
“Further understanding of whether exposure to parental SUD is a risk factor for SUD in young adults with and without ADHD has important implications, given the substantial morbidity and mortality associated with SUD (Whiteford et al., 2015).”
BackgroundQu, X., Liukasemsarn, S., Tu, J., Higgins, A., Hickey, T. J., & Hall, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.541659 · Cited by 35
Zou, S., Wang, Z., Bhura, M., & Tang, K. (2020) · Public Health · doi:10.1016/j.puhe.2022.01.021 · Cited by 29
Fodstad, E. C., Ushakova, A., Pallesen, S., Hagen, E., Erga, A. H., & Erevik, E. K. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.982763 · Cited by 31
“Substance use disorders (SUDs) are associated with adverse health outcomes and shortened life expectancy (Whiteford et al., 2015), and is characterized by a loss of control over substance use over time.”
BackgroundNurses’ perceptions of mental healthcare in primary-care settings in Kenya
Mendenhall, E., Gitonga, I., Nelson, B., Musau, A., Koon, A. D., Smith, L., Mutiso, V., & Ndetei, D. M. (2016) · Global Public Health · doi:10.1080/17441692.2016.1207196 · Cited by 28
Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands
Einarson, T. R., Bereza, B. G., Tedouri, F., Impe, K. V., Denee, T. R., & Dries, P. J. T. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1363050 · Cited by 27
Wong, H., Moore, K., Angstman, K. B., & Garrison, G. M. (2019) · BMC Family Practice · doi:10.1186/s12875-019-1015-7 · Cited by 26
“1% of Americans and is the single largest contributor to non-fatal health loss throughout the world [1, 2].”
BackgroundNavarro‐Mateu, F., Husky, M. M., Fuentes, P., Álvarez, F., Roca‐Vega, A., Rubio‐Aparicio, M., Chirlaque, M. D., Cayuela, M. L., Martínez, S., & Sánchez‐Meca, J. (2020) · Addiction · doi:10.1111/add.15312 · Cited by 29
Sorsdahl, K., Sewpaul, R., Evans, M., Naidoo, P., Myers, B., & Stein, D. J. (2018) · Journal of Health Psychology · doi:10.1177/1359105316642832 · Cited by 24
“6 million years of life lost (YLLs) equivalent to 232,000 deaths (Whiteford et al., 2015).”
BackgroundInfluentialAltun, İ. K., Turedi, N., Aras, N., & Atagün, M. İ. (2020) · Psychiatria Danubina · doi:10.24869/psyd.2020.351 · Cited by 24
“Bipolar disorder (BD) and schizophrenia are mental disorders that cause severe dysfunction (Whiteford et al. 2015).”
BackgroundFamily Support and Sociocultural Factors on Depression among Black and Latinx Sexual Minority Men
Boyd, D. T., Ramos, S. R., Quinn, C. R., Jones, K. V., Wilton, L., & Nelson, L. E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18136759 · Cited by 24
“According to previous research, major depression is common in SMM [9] and associated with a high disease burden [10].”
Bazo‐Alvarez, J. C., Bazalar-Palacios, J., Palacios, J. D. R. B., & Flores, E. C. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-064396 · Cited by 28
Göker, H. (2023) · Signal Image and Video Processing · doi:10.1007/s11760-022-02479-7 · Cited by 24
Jurado-González, F. J., García‐Torres, F., Contreras, A., Muñoz‐Navarro, R., González‐Blanch, C., Medrano, L. A., Ruiz‐Rodríguez, P., Vindel, A. C., & Moriana, J. A. (2023) · Current Psychology · doi:10.1007/s12144-023-04657-3 · Cited by 26
“There is a high comorbidity between symptoms of depression, anxiety, and somatization, which is reflected in requests for help in PC (Whiteford et al., 2015).”
NADPH Oxidases in Neurodegenerative Disorders: Mechanisms and Therapeutic Opportunities
Fiadeiro, M. B., Diogo, J. C., Silva, A., Kim, Y., & Cristóvão, A. C. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0002 · Cited by 26
Metadata
- Authors
- Whiteford, H. A., Ferrari, A. J., Degenhardt, L., Feigin, V., & Vos, T.
- Affiliations
- The University of Queensland (AU)
- The University of Melbourne (AU)
- Auckland University of Technology (NZ)
- University of Washington (US)
- Corresponding author
- Whiteford, Harvey A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-02-06
- Volume
- 10
- Issue
- 2
- Pages
- e0116820
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4320057
- OpenAlex
- W2006103193
- Semantic Scholar
- 29fdb08fe359a077ba5ecfea8813becf7defce8c
- Cited by
- 1,175
- References
- 47
- Citations by year
- 2026: 34 · 2025: 63 · 2024: 83 · 2023: 111 · 2022: 121 · 2021: 142 · 2020: 145 · 2019: 143 · 2018: 123 · 2017: 113 · 2016: 66 · 2015: 29
- FWCI
- 180.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Tuwhera (Auckland University of Technology) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Bill and Melinda Gates Foundation
- Australian Government
- University of New South Wales
- Medical Research Council
- National Health and Medical Research Council (1041742)
- National Drug and Alcohol Research Centre
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- mental illness, neurological disorders, substance use disorders, global burden of disease, disability-adjusted life years, years lived with disability, prevalence trends, sex differences, age differences, regional variation, schizophrenia, Parkinson's disease, epilepsy
- MeSH terms
- Age Factors, Bayes Theorem, Mental Disorders, Female, Geography, Humans, Male, Nervous System Diseases, Regression Analysis, Time Factors, Global Health, Prevalence, Cost of Illness, Quality-Adjusted Life Years, Substance-Related Disorders, Mortality, Premature
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.